These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 780061)

  • 21. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
    Lundback B; Rawlinson DW; Palmer JB
    Thorax; 1993 Feb; 48(2):148-53. PubMed ID: 8493629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of adding aminophylline infusion to nebulised salbutamol in severe acute asthma.
    Zainudin BM; Ismail O; Yusoff K
    Thorax; 1994 Mar; 49(3):267-9. PubMed ID: 8202885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminophilline suppress the release of chemical mediators in treatment of acute asthma.
    Nakano J; Yano T; Yamamura K; Yoshihara H; Ohbayashi O; Yamashita N; Ohta K
    Respir Med; 2006 Mar; 100(3):542-50. PubMed ID: 16337368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salbutamol in treatment of bronchial asthma--comparison of controlled release tablet with standard tablet.
    Wang CR; Yeh TS; Chuang CY; Chen CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1993 Aug; 26(3):132-7. PubMed ID: 7982368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled trial of intravenous salbutamol and aminophylline in acute asthma.
    Tribe AE; Wong RM; Robinson JS
    Med J Aust; 1976 Nov; 2(20):749-52. PubMed ID: 794661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    Dyson AJ; Mackay AD
    Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of intravenous aminophylline and salbutamol in the treatment of severe bronchospasm.
    Beswick K; Davies J; Davey AJ
    Practitioner; 1975 Apr; 214(1282):561-566. PubMed ID: 1096127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral sustained-release aminophylline and bronchodilator response to inhaled fenoterol in patients with chronic airflow obstruction.
    Carpentiere G; Marino S; Castello F; Zarcone P; Cipolla G; Baldanza C
    Chest; 1985 Oct; 88(4):576-8. PubMed ID: 4042711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute asthma. Lack of therapeutic benefit and increase of the toxicity from aminophylline given in addition to high doses of salbutamol delivered by metered-dose inhaler with a spacer.
    Rodrigo C; Rodrigo G
    Chest; 1994 Oct; 106(4):1071-6. PubMed ID: 7924475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchodilator response to oral aminophylline and terbutaline versus aerosol albuterol in patients with chronic obstructive pulmonary disease.
    Shim CS; Williams MH
    Am J Med; 1983 Oct; 75(4):697-701. PubMed ID: 6624778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous infusion of salbutamol in severe acute asthma.
    Johnson AJ; Spiro SG; Pidgeon J; Bateman S; Clarke SW
    Br Med J; 1978 Apr; 1(6119):1013-5. PubMed ID: 638577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged comparison of oral salbutamol and ephedrine aminophylline combination in byssinosis.
    Kamat SR; Salpekar VY; D'Sa E; Sanghavi B; Kamat GR
    Indian J Chest Dis Allied Sci; 1978 Apr; 20(2):63-72. PubMed ID: 363610
    [No Abstract]   [Full Text] [Related]  

  • 33. Salbutamol: tablets, inhalational powder, or nebuliser?
    Grimwood K; Johnson-Barrett JJ; Taylor B
    Br Med J (Clin Res Ed); 1981 Jan; 282(6258):105-6. PubMed ID: 6779890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of intravenous aminophylline and salbutamol in severe asthma.
    Williams SJ; Parrish RW; Seaton A
    Br Med J; 1975 Dec; 4(5998):685. PubMed ID: 1106817
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of intravenous aminophylline and salbutamol in severe asthma.
    Femi-Pearse D; George WO; Ilechukwu ST; Elegbeleye OO; Afonja AO
    Br Med J; 1977 Feb; 1(6059):491. PubMed ID: 319876
    [No Abstract]   [Full Text] [Related]  

  • 36. Preliminary experience with controlled-release aminophylline in asthmatic children: salivary levels and peak flow following a single dose.
    Evans N; Evans PW; Boobis SW
    J Int Med Res; 1979; 7 Suppl 1():93-7. PubMed ID: 374166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy, as modified by the circadian rhythm of salbutamol administered by different routes.
    Lahdensuo A; Alanko K
    Scand J Respir Dis; 1976; 57(5):231-8. PubMed ID: 792993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of sustained-release terbutaline with ordinary salbutamol in bronchial asthma.
    Beskow R; Ericsson CH; Grönneberg R; Sjögren I; Skedinger M
    Eur J Respir Dis; 1984 Oct; 65(7):509-11. PubMed ID: 6386512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative trial of slow-release aminophylline, salbutamol and a half dose combination in the prevention of childhood asthma.
    Blumenthal I
    J Int Med Res; 1980; 8(6):400-3. PubMed ID: 7439516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchospasmolytic effects of salbutamol as powder inhalation in patients with reversible bronchial obstruction.
    Deenstra M; Zanen P; Gusdorf CF
    Arzneimittelforschung; 1988 Oct; 38(10):1490-1. PubMed ID: 3058131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.